Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9 | 5075628 | intron variant | C/G | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
9 | 5075628 | intron variant | C/G | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
0.882 | 0.120 | 9 | 5078360 | missense variant | A/G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2008 | 2012 | ||||||||
|
0.882 | 0.120 | 9 | 5078360 | missense variant | A/G | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.120 | 9 | 5078360 | missense variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.120 | 9 | 5078360 | missense variant | A/G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.120 | 9 | 5078361 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2008 | 2012 | |||||||
|
0.925 | 0.120 | 9 | 5078362 | missense variant | A/C;G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2008 | 2012 | ||||||||
|
0.925 | 0.120 | 9 | 5078362 | missense variant | A/C;G;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.080 | 9 | 5089726 | missense variant | C/A;T | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.080 | 9 | 5010192 | intron variant | G/A | snv | 0.62 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.080 | 9 | 5010192 | intron variant | G/A | snv | 0.62 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.080 | 9 | 5010192 | intron variant | G/A | snv | 0.62 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.080 | 9 | 5057284 | intron variant | T/A | snv | 0.33 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 9 | 5057284 | intron variant | T/A | snv | 0.33 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.080 | 9 | 5057284 | intron variant | T/A | snv | 0.33 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.160 | 9 | 5070831 | intron variant | C/G | snv | 0.25 |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.040 | 1.000 | 4 | 2009 | 2014 | |||||||
|
0.882 | 0.160 | 9 | 5070831 | intron variant | C/G | snv | 0.25 |
|
Hemic and Lymphatic Diseases | 0.810 | 1.000 | 2 | 2009 | 2010 | |||||||
|
0.882 | 0.160 | 9 | 5070831 | intron variant | C/G | snv | 0.25 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 9 | 5070831 | intron variant | C/G | snv | 0.25 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.080 | 9 | 5072846 | intron variant | G/A | snv | 0.23 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 |